SHS Capital and ING Corporate Investments completed the acquisition of a majority stake in CAM Bioceramics.

SHS Capital and ING Corporate Investments, two private equity firms, completed the acquisition of a majority stake in CAM Bioceramics, a global manufacturer of calcium phosphate solutions for Medtech and LifeScience applications. Financial terms were not disclosed. “We are delighted to have SHS and ING Corporate Investments on board, hence enabling CAM Bioceramics to serve our customers even better and to grow even faster. The existing Shareholders and the Management Team have consciously looked for the best partners to secure continuity and get access to additional and complementary business development opportunities. The partnership with SHS and ING is a validation of our strategy and capabilities and will fuel the company’s growth even further. The Management Team will remain fully intact and will continue to provide the best Customer Satisfaction possible to remain or to become your trusted partner for innovative calcium phosphate solutions and services worldwide,” Caspar J Hogeboom, CAM Shareholder and CEO.